Á. Chopitea

1.4k total citations
43 papers, 1.0k citations indexed

About

Á. Chopitea is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Á. Chopitea has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Á. Chopitea's work include Colorectal Cancer Treatments and Studies (20 papers), Gastric Cancer Management and Outcomes (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Á. Chopitea is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Gastric Cancer Management and Outcomes (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Á. Chopitea collaborates with scholars based in Spain, Uruguay and Germany. Á. Chopitea's co-authors include Javier Rodríguez, José Ignacio Bilbao, Bruno Sangro, Mercedes Iñarrairaegui, A. Viúdez, Antonio Martínez-Cuesta, Iosu Sola, Javier Arbizu, Jorge Quiroga and J.I. Herrero and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Á. Chopitea

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Á. Chopitea Spain 17 531 489 357 302 190 43 1.0k
Javier Rodríguez Spain 14 616 1.2× 428 0.9× 348 1.0× 376 1.2× 219 1.2× 32 1.1k
Chi‐Leung Chiang Hong Kong 17 398 0.7× 401 0.8× 303 0.8× 203 0.7× 136 0.7× 88 971
Ching-Yee Oliver Wong United States 12 708 1.3× 193 0.4× 395 1.1× 324 1.1× 320 1.7× 16 1.0k
Olivier Coatmeur France 4 603 1.1× 669 1.4× 194 0.5× 330 1.1× 166 0.9× 4 1.1k
E. Tanis Netherlands 9 745 1.4× 895 1.8× 278 0.8× 424 1.4× 163 0.9× 12 1.2k
M. Luboinski France 9 451 0.8× 392 0.8× 232 0.6× 224 0.7× 53 0.3× 13 857
Hyung Jun Yoo South Korea 17 495 0.9× 262 0.5× 522 1.5× 388 1.3× 235 1.2× 34 1.2k
Stella Y. Tsai Taiwan 19 320 0.6× 471 1.0× 373 1.0× 476 1.6× 146 0.8× 25 1.3k
Michitaka Nagase Japan 18 218 0.4× 640 1.3× 836 2.3× 666 2.2× 64 0.3× 51 1.3k
Michiro Takahashi Japan 14 985 1.9× 601 1.2× 324 0.9× 526 1.7× 151 0.8× 29 1.4k

Countries citing papers authored by Á. Chopitea

Since Specialization
Citations

This map shows the geographic impact of Á. Chopitea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Á. Chopitea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Á. Chopitea more than expected).

Fields of papers citing papers by Á. Chopitea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Á. Chopitea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Á. Chopitea. The network helps show where Á. Chopitea may publish in the future.

Co-authorship network of co-authors of Á. Chopitea

This figure shows the co-authorship network connecting the top 25 collaborators of Á. Chopitea. A scholar is included among the top collaborators of Á. Chopitea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Á. Chopitea. Á. Chopitea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aliseda, Daniel, Pablo Martí‐Cruchaga, Gabriel Zozaya, et al.. (2023). Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience. Cancers. 15(3). 733–733. 12 indexed citations
2.
Vilalta, A., Azucena Aldaz, Á. Chopitea, et al.. (2023). Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma. Pancreatology. 23(4). 411–419. 1 indexed citations
3.
Betés, Maite, Ramón Angós, Á. Chopitea, et al.. (2021). Feasibility and patency of echoendoscopic anastomoses with lumen apposing metal stents depending on the gastrointestinal segment involved. Scientific Reports. 11(1). 3992–3992. 5 indexed citations
4.
Chopitea, Á., et al.. (2020). Successful Desensitization to Oxaliplatin After a Single Initial Dose of Omalizumab in a Patient With Elevated IgE Levels. Journal of Investigational Allergology and Clinical Immunology. 30(4). 293–295. 6 indexed citations
5.
Romano, P. Martin, David Cano, João Subtil, et al.. (2019). Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modeling. PLoS ONE. 14(5). e0215970–e0215970. 3 indexed citations
6.
Rodríguez, Javier, Eduardo Castañón, José Luis Perez‐Gracia, et al.. (2018). A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis. Journal for ImmunoTherapy of Cancer. 6(1). 96–96. 39 indexed citations
7.
Chopitea, Á., Fernando Pardo, Fernando Rotellar, et al.. (2017). Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience. Clinical & Translational Oncology. 20(5). 658–665. 4 indexed citations
8.
Arredondo, Jorge, Jorge Baixauli, Carlos Pastor, et al.. (2016). Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery. Clinical & Translational Oncology. 19(3). 379–385. 67 indexed citations
9.
Romano, P. Martin, J. Solà, Juan A. Díaz-González, et al.. (2016). Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer. British Journal of Cancer. 115(6). 655–663. 33 indexed citations
10.
Arredondo, Jorge, Jorge Baixauli, Carmen Beorlegui, et al.. (2013). Prognosis Factors for Recurrence in Patients With Locally Advanced Rectal Cancer Preoperatively Treated With Chemoradiotherapy and Adjuvant Chemotherapy. Diseases of the Colon & Rectum. 56(4). 416–421. 32 indexed citations
11.
Rodríguez, J., Valentina Boni, Andrea Hernández, et al.. (2011). Association of RRM1 –37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy. European Journal of Cancer. 47(6). 839–847. 18 indexed citations
12.
Díaz-González, Juan A., Javier Rodríguez, José Luís Hernández-Lizoáin, et al.. (2010). Patterns of Response After Preoperative Treatment in Gastric Cancer. International Journal of Radiation Oncology*Biology*Physics. 80(3). 698–704. 18 indexed citations
13.
Zárate, Ruth, Javier Rodríguez, Eva Bandrés, et al.. (2010). Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis. British Journal of Cancer. 102(6). 987–994. 40 indexed citations
14.
Rodríguez, Javier, Nerea Bitarte, Ruth Zárate, et al.. (2010). Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients. British Journal of Cancer. 103(10). 1529–1535. 16 indexed citations
15.
Rodríguez, J., A. Viúdez, Mariano Ponz‐Sarvisé, et al.. (2009). Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab. Critical Reviews in Oncology/Hematology. 74(3). 193–202. 23 indexed citations
16.
González‐Cao, María, Santiago Viteri, Ángel Díaz‐Lagares, et al.. (2008). Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma. Oncology. 74(1-2). 12–16. 42 indexed citations
17.
Sangro, Bruno, Javier Rodríguez, Iosu Sola, et al.. (2008). Liver disease induced by radioembolization of liver tumors. Cancer. 112(7). 1538–1546. 252 indexed citations
18.
Chopitea, Á., et al.. (2006). Algunos instrumentos de evaluación utilizados en Cuidados Paliativos (II): el Cuestionario Breve de Dolor (Brief Pain Inventory, BPI). Medicina Paliativa. 13(1). 37–42. 2 indexed citations
19.
Cao, María González, Gorka Bastarrika, Jesús García‐Foncillas, et al.. (2006). Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement. Clinical & Translational Oncology. 8(5). 369–371. 4 indexed citations
20.
Perez‐Gracia, José Luis, María del Mar Muñoz, Grant Williams, et al.. (2005). Assessment of the value of confirming responses in clinical trials in oncology. European Journal of Cancer. 41(11). 1528–1532. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier Rodríguez Breakdown of academic impact, for papers by Chi‐Leung Chiang Breakdown of academic impact, for papers by Ching-Yee Oliver Wong Breakdown of academic impact, for papers by Olivier Coatmeur Breakdown of academic impact, for papers by E. Tanis Breakdown of academic impact, for papers by M. Luboinski Breakdown of academic impact, for papers by Hyung Jun Yoo Breakdown of academic impact, for papers by Stella Y. Tsai Breakdown of academic impact, for papers by Michitaka Nagase Breakdown of academic impact, for papers by Michiro Takahashi
Rankless by CCL
2026